GlassScriptPhysician profile
Dan S Heffez
NPI 1841232725
$30,894.49
in general payments reported to CMS, 2019-2025
3 companies · $3,985 in 2025
The $3,985 reported for 2025 was more than what 78% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,578 · 2020: $5,435 · 2021: $5,763 · 2022: $4,090 · 2023: $3,660 · 2024: $4,384 · 2025: $3,985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $12K · Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $11,884.84 |
| Food and Beverage | $144.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $30,650.84 | 2019-2025 | Neuro, Neuro Ti |
| Spineology INC. | $144.66 | 2025 | |
| Cerapedics INC. | $98.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Heffez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.